Zobrazeno 1 - 6
of 6
pro vyhledávání: '"G. Lopez-Argumedo"'
Autor:
Ramón Barceló, A. Muñoz, Itziar Rubio, Ainhoa Viteri, A. Ruiz de Lobera, I. Diaz de Corcuera, Guillermo Lopez-Vivanco, A. Gil-Negrete, Sergio Carrera, G. Lopez-Argumedo
Publikováno v:
Journal of Clinical Oncology. 24:13509-13509
13509 Background: AC is indicated for stage III and high risk stage II colon cancer, as well as for stages II-III rectal cancers combined with RT. Moreover, chemotherapy improves survival in metastatic disease. There are no randomised trials evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c39aa313068ff1c3142bb20788fb2b36
https://doi.org/10.1200/jco.2006.24.18_suppl.13509
https://doi.org/10.1200/jco.2006.24.18_suppl.13509
Autor:
A. Martinez-Bueno, G. Lopez-Argumedo, Itziar Rubio, Ramón Barceló, R. Fernández, Guillermo Lopez-Vivanco, J. M. Mañé, I. Diaz de Corcuera, Aintzane Sancho, A. Muñoz
Publikováno v:
Journal of Clinical Oncology. 24:15516-15516
15516 Background: Concomitant CRT has become a standard treatment for advanced head and neck cancer. The aim of this study was to evaluate the efficacy and toxicity of concurrent CRT with D in patients (pts) with advanced squamous cell carcinoma of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7e6faef2cdcd1dd04a4613a1cff9037
https://doi.org/10.1200/jco.2006.24.18_suppl.15516
https://doi.org/10.1200/jco.2006.24.18_suppl.15516
Autor:
G. Lopez-Argumedo, A. Martinez-Bueno, Guillermo Lopez-Vivanco, N. Fuente, Itziar Rubio, R. Fernández, Sergio Carrera, Ramón Barceló, A. Muñoz, A. Gil-Negrete
Publikováno v:
Journal of Clinical Oncology. 24:18505-18505
18505 Background: Lung cancer is increasingly diagnosed in elderly patients and is the first cause of cancer death. Treatment of this subset represents a challenge to medical oncologists. Methods: We retrospectively reviewed clinical characteristics,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::620345dbbe8474de815653a8d87c8e4d
https://doi.org/10.1200/jco.2006.24.18_suppl.18505
https://doi.org/10.1200/jco.2006.24.18_suppl.18505
Autor:
A. Gil-Negrete, Alberto Muñoz, J. Muhialdin, Ramón Barceló, Itziar Rubio, S. Carrera, J. M. Mañé, Guillermo Lopez-Vivanco, G. Lopez-Argumedo
Publikováno v:
Lung Cancer. 49:S267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c6ace80520bce65769562be002ea2aa
https://doi.org/10.1016/s0169-5002(05)81061-x
https://doi.org/10.1016/s0169-5002(05)81061-x
Autor:
A. Muñoz, T. Perez-Hoyos, G. Lopez-Argumedo, N. Fuente, R. Barcelo-Galindez, Guillermo Lopez-Vivanco, R. Fernández, Ainhoa Viteri, Itziar Rubio, J. M. Mañé
Publikováno v:
Journal of Clinical Oncology. 22:4187-4187
4187 Background: Combination chemotherapy improves overall survival and quality of life in metastatic gastric cancer. Capecitabine (CAP), a new oral fluoropyrimidine has shown equivalent activity, ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f2a6ee22e23c99f24083e0078d140ef
https://doi.org/10.1200/jco.2004.22.90140.4187
https://doi.org/10.1200/jco.2004.22.90140.4187
Autor:
A. Muñoz, T. Perez-Hoyos, Itziar Rubio, Ainhoa Viteri, J. Ferreiro, J. M. Mañé, G. Lopez-Argumedo, R. Barcelo-Galindez, N. Fuente, Guillermo Lopez-Vivanco
Publikováno v:
Journal of Clinical Oncology. 22:3701-3701
3701 Background: Oxaliplatin (OX) combined with c.i. 5FU is one of the most active first line treatments for patients with MCRC. Recently its efficacy has been demonstrated after CPT11-based chemot...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bfef1a83a30b8f68662ec4c9f92cd81
https://doi.org/10.1200/jco.2004.22.90140.3701
https://doi.org/10.1200/jco.2004.22.90140.3701